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Objectives: There is widespread commitment—at least in principle—to “evidence-informed” clinical practice and policy development in health care. The intention is that only
“appropriate” care ought to be delivered at public expense. Although the rationale for an appropriateness agenda is widely endorsed, and methods have been proposed for
addressing it, few published studies exist of contemporary policy initiatives which have actually led to successful disinvestment. Our objective was to explore whether the direct
involvement of policy stakeholders could advance appropriateness and disinvestment.
Methods: Several collaborative engagements with policy stakeholders were undertaken to adapt and combine conceptual and empirical material related to appropriateness and
disinvestment from the literature to create tools and processes for use in Canada and the province of Ontario in particular.
Results: By combining inputs from the literature with colloquial evidence from policy stakeholders, a definition of appropriateness was developed and, importantly, endorsed by all
the provincial and territorial ministers of health in Canada. Second, a reassessment framework was successfully implemented for identifying priorities for selective disinvestment.
Conclusions: When scientific evidence was combined with colloquial evidence from policy stakeholders, progress was made on the design and successful implementation of policies
for appropriateness and disinvestment.
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There is unprecedented interest in decreasing the frequency of
unnecessary medical tests and procedures. International exam-
ples include the Choosing Wisely campaign (1), the United
States Preventative Services Task Force (USPTF) grade C and
D recommendations (2), the National Institute for Health and
Care Excellence (NICE) “do not do” resources (3), and Aus-
tralia’s federal Quality Management Framework of the Medicare
Benefits Schedule (4). In Canada, Health Quality Ontario has
an “appropriateness initiative” (5), Choosing Wisely Canada
has been launched (6) and appropriateness has been identified
as a national priority by Canadian provincial and territorial
premiers (7). Notwithstanding the numerous “lists” that iden-
tify potential low-value services, prioritizing and implement-
ing disinvestments from within those lists still pose challenges
(8–13). Political and social factors can be barriers to evidence-
informed disinvestment—once a product or service is funded,
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Policy stakeholders and disinvestment
withdrawing support for it, wholly or in part, is much harder
than deciding not to support it in the first place. Expert and
professional opinion, political judgment, the interpretation of
local values and traditions, and views from stakeholders are
all factors that inform and constrain decision making (13–15).
Although the literature generally supports stakeholder “owner-
ship” of policy decisions (14–18), few publications detail how
policy stakeholders should be involved and what, specifically,
they can contribute. Our objective was to explore the involve-
ment of policy stakeholders in the design and implementation
of tools and processes related to appropriateness and disinvest-
ment in Canada, and the province of Ontario in particular, and
to assess their effectiveness.
METHODS
The authors performed a literature review and engaged with
health technology assessment (HTA) experts to identify litera-
ture related to appropriateness and disinvestment. The general
method was then to engage with Canadian policy stakeholders,
primarily government staff but also HTA experts and clinicians
with policy (nontechnical/clinical) influence, regarding the best
ways of adapting and combining ideas and evidence from the
literature to create tools and processes that would be directly
useful in defining appropriateness and enabling disinvestment.
Government staff (rather than independent researchers) served
as knowledge brokers with the role of summarizing and pre-
senting research evidence to groups of policy stakeholders. In
engaging with policy stakeholders, the knowledge brokers em-
phasized an intention to combine technical concepts and empir-
ical findings as reported in the literature with the stakeholders’
understanding of local contexts, their judgments of feasibility
of implementation and their policy values.
Regarding “appropriateness,” the process began with a pre-
liminary definition drafted by the authors and based on a World
Health Organization report (19) and concepts from Health Qual-
ity Ontario (5). The Health Support Committee is a network of
Canadian policy staff through which provincial and territorial
ministries collaborate and share information. The preliminary
definition of appropriateness was sent to fifty-three government
staff members of the Health Support Committee and an addi-
tional seventeen stakeholders (some individuals and some orga-
nizations) with potential contributions to make to policy. These
included the Canadian Medical Association’s affiliated societies
and other medical/professional organizations and associations.
The definition was refined based on suggestions provided by
twenty-eight respondents representing seventeen professional
healthcare provider associations and eleven provinces and ter-
ritories. It was then brought to the national Health Care Inno-
vation Working Group, co-chaired by two provincial premiers
and comprising all provincial and territorial ministers of health,
who endorsed it in March 2013.
The Ontario “reassessment framework” was based on 16 cri-
teria proposed by Elshaug et al. (20) The authors worked with
an ad hoc internal ministry committee specifically created to
address disinvestment, with additional advice from local exter-
nal clinical and HTA experts, to select a subset of the Elshaug
criteria and refine them to serve as “triggers” for identifying
priorities for reassessment among existing funded technologies
and services in Ontario. The ad hoc committee had responsibil-
ity for applying the triggers to identify priority candidates for
reassessment, and communicating information about specific
reassessment candidates to the policy managers and staff who
would have responsibility for acting on them.
RESULTS
The definition of “appropriateness” was agreed by Canadian
provincial and territorial ministers of health in March 2013:
In the context of health care, appropriateness is the proper or correct use
of health services, products, and resources. Inappropriate care, in contrast,
can involve overuse, underuse, and/or misuse of health services, products,
and resources.
Appropriateness is primarily determined by analyses of the evidence of
clinical effectiveness, safety, economic implications, and other health sys-
tem impacts.
The practical application of appropriateness is made when these analyses
are qualified by (a) clinician judgment, particularly in atypical circum-
stances, and (b) societal and ethical principles and values, including patient
preferences.
The Ontario reassessment framework was established as a set
of seven criteria (triggers) adapted from the sixteen criteria pro-
posed by Elshaug et al. (20) Local policy stakeholders identified
triggers that (a) would identify reassessment candidates which
would be considered valid from the policy-maker perspective
and (b) were implementable with existing data sources in On-
tario. Under the Ontario reassessment framework, priority can-
didates were those that met two or more of the following seven
triggers (some of which have the quantitative requirements in-
dicated in brackets): (trigger 1) an evidence-based recommen-
dation against use by an external body; (trigger 2) nominated
by a local clinical expert; (trigger 3) safety concerns noted in
the literature; (trigger 4) regional and/or temporal variation sug-
gesting inappropriate use; (trigger 5) change likely to provide
benefit to a significant number of people in Ontario (criterion:
change would have positive impact for least 1,000 individuals
per year); (trigger 6) change would be cost saving (criterion:
change would result in cost savings of at least $1 million per
year); (trigger 7) data suggesting that a significant percentage of
patients received inappropriate services or products (criterion:
no threshold set, but a working limit of not less than 10% of
relevant patient cases may be reasonable, except in cases where
clinical experts specify a different limit).
The application of the Ontario reassessment framework did
not require information about every trigger for each possible
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candidate. The emphasis was on gathering sufficient rather than
complete information to determine whether further assessment
was warranted. The framework documents clearly stated that
absence of evidence related to a trigger was not to be interpreted
as evidence that the trigger was not met.
The Ontario reassessment framework identified candidates
that have since proceeded to selective disinvestment, resulting in
an estimated $59 million per year (CDN$) freed up for invest-
ment elsewhere. For example, partial disinvestment has been
implemented in Ontario for routine vitamin B12 testing, rou-
tine ferritin testing, and daily use of diabetes test strips by people
with diabetes who do not take insulin. Each of these practices
was a priority for reassessment based on triggers 1 and 6 of the
reassessment framework and, after further involvement of local
stakeholders (without additional external context-free scientific
evidence), selective disinvestment was implemented.
The Ontario reassessment framework was also used by the
ad hoc ministry committee for disinvestment to identify priority
candidates from a list of potential low value practices in Aus-
tralia (21). Of 156 items on the Australian list, 16 were readily
identified as potential Ontario priorities: twelve were flagged
by Choosing Wisely, USPSTF and/or NICE recommendations
(trigger 1), four others were identified as potential priorities by
internal ministry clinical experts (trigger 2). Of these sixteen
items, nine had been assessed or addressed in Ontario before
the creation of the ad hoc committee and did not require further
committee attention. All available trigger information for the
remaining seven candidates was brought forward for consider-
ation by the ad hoc ministry committee.
Three of the seven practices related to diagnostic imaging
in children. Based on their presence on the Australian list of low
value or harmful practices (trigger 1), regional variation with no
apparent justification (trigger 4) and possible safety issues re-
lated to unnecessary medical radiation (trigger 3), reassessment
was recommended for these practices, and is now in progress.
The remaining four practices related to cancer screening or
treatment. In each case the literature suggested that a practice
was appropriate only for specific risk groups. The internal com-
mittee identified unexplained regional variation (trigger 4) but
did not have access to risk information for Ontario patients re-
ceiving the practice. The committee consequently referred the
reassessment candidates to another technical group for addi-
tional research.
DISCUSSION
Significant challenges affect the implementation of disinvest-
ment. These include political and social barriers which require
the involvement of policy stakeholders for resolution. Lomas
et al. describe three different categories of evidence: medical
effectiveness research (context-free scientific evidence);
social science-oriented research (context-sensitive scientific
evidence); and the expertise, views, values, and realities of
stakeholders (colloquial evidence) (15). The three categories
are not mutually exclusive as each has a role to play in
producing evidence-based guidance for the health system
(15). The paucity of examples of successful disinvestment,
despite supporting scientific evidence, suggests that colloquial
evidence has a major influence, and much literature suggests
the importance of colloquial evidence as complementary input
if HTAs are to have their intended impact (14;22;23). As
described below, the involvement of policy stakeholders, and
the combination of their colloquial evidence with scientific ev-
idence, assisted the development of tools and processes related
to appropriateness and disinvestment in Canada and Ontario.
The revisions to the appropriateness definition that were
made based on policy stakeholders’ input, as shown in capi-
tal letters below, clearly reflect colloquial evidence including
values, pragmatics, resources, and professional experience and
expertise.
IN THE CONTEXT OF HEALTH CARE, appropriateness is the proper or
correct use of health services, products AND RESOURCES. Inappropriate
care, in contrast, can involve overuse, underuse and/or misuse of health
services, products AND RESOURCES.
Appropriateness is primarily determined by analyses of the evidence of
CLINICAL effectiveness, SAFETY, economic implications, and other
health system impacts.
The PRACTICAL APPLICATION of appropriateness is made when these
analyses are qualified by (A) CLINICIAN JUDGMENT, PARTICULARLY
IN ATYPICAL CIRCUMSTANCES AND (B) societal and ethical princi-
ples and values, INCLUDING PATIENT PREFERENCES.
Notably, the finally agreed definition of appropriateness inte-
grated each of the three categories of evidence: clinical effec-
tiveness evidence was a form of context-free scientific evidence,
economic implications represented context-sensitive scientific
evidence, and clinician judgement and patient preferences were
examples of colloquial evidence.
The triggers of the Ontario reassessment framework, which
were selected through deliberation with local policy stakehold-
ers, also included each of the three categories of evidence.
Trigger 1, “an evidence-based recommendation by an external
body,” will often involve consideration of context-free scientific
evidence from other jurisdictions. Trigger 6, “change would be
cost saving,” prompts consideration of context-sensitive scien-
tific evidence. Trigger 2, “nominated by a local clinical ex-
pert,” may be exclusively evaluated based on colloquial evi-
dence, for example, reflecting clinicians’ professional experi-
ence/expertise.
Local stakeholder involvement was essential for success-
ful implementation of selective disinvestment. For example, the
Ontario reassessment framework identified vitamin B12 and
ferritin laboratory testing as reassessment candidates in Novem-
ber 2011. Implementing changes, however, involved months of
work including validation by local HTA experts (24) and gov-
ernment staff working with a table of stakeholders from the
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Ontario laboratory sector to identify the best implementation
option—removal of the check boxes for those tests from the
standard laboratory test ordering form.
Policy stakeholder input also contributed to a decision not
to disinvest. One priority for reassessment was identified based
on published evidence that the practice was of low value;
however, given the absence of evidence of harm in the lit-
erature, and local policy stakeholder advice that the practice
was provided infrequently for a small number of people in
Ontario, reassessment and selective disinvestment were not
pursued.
The mechanisms and processes for obtaining policy stake-
holder contributions were also important. For example, each
of the first five priority candidates identified by the reassess-
ment framework were already being considered for reassess-
ment and/or disinvestment at some level within government
departments, but had not been acted on. Collectively, the for-
mation of the ad hoc committee, the provision of context-free
scientific evidence related to it, opportunities for group discus-
sion and a high degree of agreement between the internal ad
hoc ministry committee members all strengthened committee
members’ resolve and interest in specific disinvestment oppor-
tunities.
Although the ad hoc committee on disinvestment was ini-
tially formed to respond to a “push” of research evidence from
the authors (25), it has been succeeded by a standing ministry
committee that exercises a “pull” for research evidence on a
regular basis.
CONCLUSIONS
Scientific evidence combined with and qualified by colloquial
evidence from policy stakeholders was a recurring theme:
(i) A definition of appropriateness was developed by using
policy stakeholder input to modify and adapt text from the
literature—the result was a definition which included explicit
reference to including colloquial evidence in determining ap-
propriateness. (ii) The Ontario reassessment framework was
developed through work with local policy stakeholders to
adapt a framework from the literature for Ontario—the re-
sult was a framework which included criteria based on collo-
quial evidence. (iii) Implementation of selective disinvestment
integrated scientific evidence with colloquial evidence in the
forms of practical advice and values inputs from local policy
stakeholders.
By using a method that combined and qualified scientific
evidence with colloquial evidence from policy makers, progress
was made on appropriateness in Canada and Ontario. Although
the definition of appropriateness and the design of the reassess-
ment framework were specifically tailored for the Ontario and
Canadian context, the fact that these arrangements succeeded in
integrating policy-makers’ colloquial evidence and have been
successfully implemented, may make them a good starting point
for related work in other jurisdictions and settings.
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